Markets

HDC 2025 in Sanya showcased advancements in the HarmonyOS ecosystem, specifically focusing on streamlining app development. Huawei spearheaded the unveiling of the HarmonyOS Application Open Source Component Technical Map, a collaborative effort with partners to create a comprehensive library of open-source components. This initiative aims to reduce redundant coding, accelerate development cycles, and foster a thriving environment for developers, featuring 1115 open-source libraries and 7 cross-platform frameworks. The event included presentations from industry leaders demonstrating successful framework integrations and the growth of the HarmonyOS platform.

At HDC 2025, the “HarmonyOS Era Partners” zone showcased young, independent developers creating innovative apps. These creators, from diverse backgrounds, are thriving due to the platform’s open access and focus on user connection. Success stories like “Light Countdown” and “Daily Coffee” highlight the ecosystem’s potential for fostering impactful and people-centric technology, driving growth through collaboration and pushing the boundaries of what’s possible.

Labubu, a collectible toy, is experiencing a global boom. Actress Yao Chen revealed she invested in Labubu early, witnessing its rise from criticism to immense popularity, including limited-edition figures. Initially popular in Southeast Asia, Labubu’s sales have exploded worldwide, driven by celebrity endorsements and high demand (leading to secondary market price increases). The company’s CEO aims to develop Labubu into a long-term intellectual property.

Mathematician Wei Dongyi gained viral fame on Douyin, accumulating over 24 million followers in three days. The World Record Certification Agency recognized his rapid follower growth. His account will feature mathematics content, connecting him with a wider audience. Sohu CEO Zhang Chaoyang acknowledged Wei’s social media presence as natural, highlighting the shift towards social media for educational content and publications.

Russian daredevil Sergey Boitsov set a world record on June 19th by performing high-bar routines at 1,500 meters above ground, suspended from a hot air balloon with no safety net or parachute. Reports from CNBC AI News showcase the dangerous feat, which included a full-swinging giant. The stunt has garnered significant attention, with social media reactions ranging from awe to disbelief, praising Boitsov’s courage.

In China, a man sparked a cross-country car theft spree after balking at the price of a return flight. The suspect, named Chen, allegedly stole multiple vehicles across several provinces, using them for transportation. He was apprehended after stealing eight cars in total and attempting to return to Dalian. All stolen vehicles have been recovered, and charges are pending.

China is boosting its consumer market with a new round of subsidies to encourage the replacement of old goods. ¥138 billion (approximately $19 billion USD) in central government funds will be released in Q3 and Q4, following the distribution of ¥162 billion in the first half of the year. The program is part of a larger initiative with a total of ¥300 billion allocated and currently about 50% utilized, covering appliances, electronics, and vehicles. Local governments are also expected to contribute.

Elon Musk plans to revamp humanity’s knowledge base using Grok 3.5/4, addressing the issue of misinformation in current AI models. The model will rewrite the human knowledge repository, correcting errors and filling gaps for subsequent retraining. Grok is designed to identify and eliminate inaccuracies, aiming to be the ultimate knowledge curator and counter the rise of AI-generated fabricated content.

Please provide the content you would like me to summarize. I need the text to create a concise English abstract for it.

Innovent Biologics will present at the ADA’s 85th Scientific Sessions, unveiling research on its pipeline for metabolic disease. Key highlights include IBI3030, a novel anti-PCSK9 antibody conjugate, and promising results on mazdutide, a dual GCG/GLP-1 receptor agonist. Mazdutide data will focus on liver fat reduction, MASH and fibrosis improvement, and uric acid reduction. The presentation will feature results from preclinical studies and investigator-initiated trials, pointing to Innovent’s focus on innovative metabolic disease therapies.